ArticleClinical optometry2026
Satisfaction of Biweekly Senofilcon A Toric Contact Lens Wearers Who Were Refit Into Weekly Serafilcon A Toric Contact Lenses.
Article in Clinical optometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The purpose of this study was to determine whether satisfied wearers of biweekly contact lenses (CL) for astigmatism can be refitted with weekly CL for astigmatism and remain satisfied wearers. Methods: Satisfied, asymptomatic senofilcon A CL wearers aged 18-40 years were enrolled. Visits 1 and 2 confirmed senofilcon A CL satisfaction and fit. After a week of washout, serafilcon A CLs were dispensed at visit 3, and participants were asked to wear them for 2 weeks. At visit 4, CLs were evaluated using the CLDEQ-8, visual analog scale (VAS), an investigator-designed questionnaire, and the Impact of Dry Eye on Everyday Life (IDEEL) QoL module. Results: Forty-seven participants (70.2% female) were enrolled. A total of 81% of the participants wearing serafilcon A CLs had asymptomatic CLDEQ-8 scores at visit 4. Serafilcon A CLs wearers had mean VAS scores of 72.1 ± 27.2 for end of day eye comfort, 63.6 ± 34.2 for eye dryness, and 79.6 ± 23.8 for clarity of vision. Serafilcon A CLs wearers had good mean daily activities (96.1 ± 5.3), feelings (97.8 ± 3.2), and work domain (95.7 ± 5.9) IDEEL questionnaire scores, and 65.8% of the participants indicated that they were satisfied with their CLs. Conclusion: According to patient reported outcome results, most participants were satisfied with their CLs after switching from senofilcon A to serafilcon A CLs, suggesting that it is feasible to switch a satisfied biweekly CL wearer to a weekly CL brand when needed as a result of newer materials, a different replacement schedule, patient preference, costs, or other necessities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.